Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.
Perrone V, Veronesi C, Cappuccilli M, Andretta M, Bacca M, Barbieri A, Bartolini F, Brega A, Cillo MR, Colasuonno F, Dell'Orco S, Ferrante F, Grego S, Lavalle A, Mancini D, Pastorello M, Pagliaro R, Procacci C, Scandolara C, Schiavone P, Ubertazzo L, Valpondi P, Vercellone A, Zucchi A, Ciappetta M, Lucatelli D, Cinti Luciani A, Degli Esposti L.
Perrone V, et al. Among authors: degli esposti l.
Epilepsia. 2025 Oct 24. doi: 10.1111/epi.18673. Online ahead of print.
Epilepsia. 2025.
PMID: 41134104